Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy

Abstract

Gamma-emitting radiopeptides are useful for scintigraphy of tumours on the basis of receptor binding. Likewise, β-emitting radiopeptides may be used in radionuclide therapy of such tumours. As iodine-131 suggested to be suitable for this purpose, experiments were performed using three somatostatin analogues, in which the effects of coupling of a therapeutic… (More)
DOI: 10.1007/BF00843706

Topics

6 Figures and Tables

Cite this paper

@article{Bakker1996Iodine131LO, title={Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy}, author={Willem H. Bakker and Wout A. P. Breeman and Marcel E. van der Pluijm and Marion de Jong and Theo J. Visser and Eric P. Krenning}, journal={European Journal of Nuclear Medicine}, year={1996}, volume={23}, pages={775-781} }